Filing Details
- Accession Number:
- 0001213900-21-006210
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-02 17:05:40
- Reporting Period:
- 2021-02-01
- Accepted Time:
- 2021-02-02 17:05:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1553643 | Relmada Therapeutics Inc. | RLMD | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1117167 | J Charles Casamento | C/O Relmada Therapeutics, Inc. 880 Third Avenue, 12Th Floor New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-01 | 1,337 | $33.30 | 20,613 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-01 | 1,663 | $33.90 | 18,950 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- Sales prices range from $32.68 to $33.59 per share, inclusive.
- Sales prices range from $33.70 to $34.00 per share, inclusive.
Billionaire Hedge Funds
